A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Effects of Donepezil Hydrochloride (E2020) in the Management of Patients with Alzheimer’s Disease in a Nursing Home Facility
E2020-A001-311
Study Overview
E2020
donepezil
Not available
Sep 1996 - Apr 1998
Alzheimer's disease
The primary efficacy endpoint was to evaluate the efficacy (primary efficacy parameter NPI-NH 10 item) of donepezil HCI E2020, versus Placebo, in the management of Alzheimer's disease patients in a nursing home facility.
The clinical study report (CSR) synopses, plain language results summaries (PLS) and plain language protocol synopses (PLPS) contained on this website are from clinical trials sponsored by Eisai and are provided for informational purposes only. These summaries and synopses contain data from and about the specific study population but do not include patient-level data from each study participant. The results reported in any single trial may not reflect the overall potential risks or benefits associated with Eisai’s products.
Only health care professionals may determine if a specific product is appropriate as a treatment option for a particular patient. Health care professionals should refer to the specific labelling information approved in their country when making prescribing decisions.
The information provided is not intended to commercialize or promote Eisai’s products for any unapproved uses.
All reasonable precautions have been taken to ensure the accuracy, security and confidentiality of information contained on this website. Eisai reserves the right to amend any information on this website at any time at its sole discretion.
If you have questions about any clinical trial results or protocols available on this website, please speak with the doctor, research nurse, or other team member at your trial site.
By clicking “Accept” you are acknowledging that you have read and understood this statement.
Plain Language Protocol Synopsis (PLPS)
No download available
Plain Language Summary of Results (PLS)
No download available
Publication reference citation
Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, et al. A randomized, double-blind, placebocontrolled study of the efficacy and safety of donepezil in patients with Alzheimer’s disease in the nursing home setting. J Am Geriatr Soc. 2001;49:1590-9.
Data Sharing
ClinicalStudyDataRequest.com (CSDR) is a multi sponsor site through which qualified researchers who wish to access clinical trial data and associated information in order to conduct further research can submit their research proposal or enquiry.
CSDR Sharing is available for this study.
CSDR
Availability
Clinical Trial Data
Redacted documents may be available upon request for this study.